{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T02:15:20Z","timestamp":1793931320746,"version":"4.8.0"},"reference-count":119,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T00:00:00Z","timestamp":1735776000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>The connections between sarcopenia and various chronic conditions, including type 2 diabetes (T2DM), metabolic syndrome (MetS), and liver disease have been highlighted recently. There is also a high occurrence of sarcopenia in metabolic dysfunction-associated steatotic liver disease (MASLD) patients, who are often disregarded. Both experimental and clinical findings suggest a complex, bidirectional relationship between MASLD and sarcopenia. While vitamin D, testosterone, and specific drug therapies show promise in mitigating sarcopenia, consensus on effective treatments is lacking. Recent focus on lifestyle interventions emphasizes dietary therapy and exercise for sarcopenic obesity in MASLD. Challenges arise as weight loss, a primary MASLD treatment, may lead to muscle mass reduction. The therapeutic approach to sarcopenia in morbidly obese MASLD patients also includes bariatric surgery (BS). BS induces weight loss and stabilizes metabolic imbalances, but its impact on sarcopenia is nuanced, underscoring the need for further research. Our aim is to provide a comprehensive review of the interplay between sarcopenia and MASLD and offer insight into the most recent therapeutic challenges and discoveries, as sarcopenia is often overlooked or unrecognized and poses significant challenges for managing these patients.<\/jats:p>","DOI":"10.3390\/nu17010178","type":"journal-article","created":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T10:32:26Z","timestamp":1735813946000},"page":"178","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Sarcopenia in MASLD\u2014Eat to Beat Steatosis, Move to Prove Strength"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1627-9670","authenticated-orcid":false,"given":"Dana","family":"Cri\u015fan","sequence":"first","affiliation":[{"name":"Faculty of Medicine, \u201cIuliu Hatieganu\u201d University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania"},{"name":"Clinical Municipal Hospital, 400139 Cluj-Napoca, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2656-3234","authenticated-orcid":false,"given":"Lucre\u0163ia","family":"Avram","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, \u201cIuliu Hatieganu\u201d University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania"},{"name":"Clinical Municipal Hospital, 400139 Cluj-Napoca, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreea","family":"Morariu-Barb","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, \u201cIuliu Hatieganu\u201d University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania"},{"name":"Regional Institute of Gastroenterology and Hepatology \u201cProf. Dr. Octavian Fodor\u201d, 400162 Cluj-Napoca, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiana","family":"Grapa","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, \u201cIuliu Hatieganu\u201d University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania"},{"name":"Regional Institute of Gastroenterology and Hepatology \u201cProf. Dr. Octavian Fodor\u201d, 400162 Cluj-Napoca, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioana","family":"Hiri\u015fcau","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, \u201cIuliu Hatieganu\u201d University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5872-8630","authenticated-orcid":false,"given":"Rare\u015f","family":"Cr\u0103ciun","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, \u201cIuliu Hatieganu\u201d University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania"},{"name":"Regional Institute of Gastroenterology and Hepatology \u201cProf. Dr. Octavian Fodor\u201d, 400162 Cluj-Napoca, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0231-2131","authenticated-orcid":false,"given":"Valer","family":"Donca","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, \u201cIuliu Hatieganu\u201d University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania"},{"name":"Clinical Municipal Hospital, 400139 Cluj-Napoca, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0600-6097","authenticated-orcid":false,"given":"Andrada","family":"Neme\u015f","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, \u201cIuliu Hatieganu\u201d University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania"},{"name":"Clinical Municipal Hospital, 400139 Cluj-Napoca, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,1,2]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1097\/MCO.0b013e328312c37d","article-title":"Sarcopenic obesity: Definition, cause and consequences","volume":"11","author":"Stenholm","year":"2008","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"ref_2","first-page":"16","article-title":"Writing Group for the European Working Group on Sarcopenia in Older People 2 (EWGSOP2), and the Extended Group for EWGSOP2 (2019). Sarcopenia: Revised European consensus on definition and diagnosis","volume":"48","author":"Bahat","year":"2019","journal-title":"Age Ageing"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1093\/gerona\/glu010","article-title":"The FNIH sarcopenia project: Rationale, study description, conference recommendations, and final estimates","volume":"69","author":"Studenski","year":"2014","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1111\/jgs.16372","article-title":"Sarcopenia Definition: The Position Statements of the Sarcopenia Definition and Outcomes Consortium","volume":"68","author":"Bhasin","year":"2020","journal-title":"J. Am. Geriatr. Soc."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.numecd.2007.10.002","article-title":"Sarcopenic obesity: A new category of obesity in the elderly","volume":"18","author":"Zamboni","year":"2008","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"392","DOI":"10.3350\/cmh.2018.0011","article-title":"The Association of leptin with severity of non-alcoholic fatty liver disease: A population-based study","volume":"24","author":"Rotundo","year":"2018","journal-title":"Clin. Mol. Hepatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1677\/joe.0.1750405","article-title":"Leptin directly regulates bone cell function in vitro and reduces bone fragility in vivo","volume":"175","author":"Cornish","year":"2002","journal-title":"J. Endocrinol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.metabol.2018.11.014","article-title":"Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics","volume":"92","author":"Polyzos","year":"2019","journal-title":"Metabolism"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.cell.2012.02.017","article-title":"Mechanisms for insulin resistance: Common threads and missing links","volume":"148","author":"Samuel","year":"2012","journal-title":"Cell"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1152\/physrev.00063.2017","article-title":"Mechanisms of Insulin Action and Insulin Resistance","volume":"98","author":"Petersen","year":"2018","journal-title":"Physiol. Rev."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s12944-024-02108-x","article-title":"Updated mechanisms of MASLD pathogenesis","volume":"23","author":"Li","year":"2024","journal-title":"Lipids Health Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.metabol.2016.02.014","article-title":"Molecular mechanisms of lipotoxicity and glucotoxicity in nonalcoholic fatty liver disease","volume":"65","author":"Mota","year":"2016","journal-title":"Metab. Clin. Exp."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/2044-5040-2-2","article-title":"TNF-\u03b1- and tumor-induced skeletal muscle atrophy involves sphingolipid metabolism","volume":"2","author":"Zufferli","year":"2012","journal-title":"Skelet. Muscle"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1152\/japplphysiol.01011.2018","article-title":"Role of mTORC1 in mechanically induced increases in translation and skeletal muscle mass","volume":"127","author":"Goodman","year":"2019","journal-title":"J. Appl. Physiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.physbeh.2007.12.002","article-title":"Muscular diacylglycerol metabolism and insulin resistance","volume":"94","author":"Timmers","year":"2008","journal-title":"Physiol. Behav."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"E1315","DOI":"10.1152\/ajpendo.00561.2011","article-title":"Lipid metabolism in skeletal muscle: Generation of adaptive and maladaptive intracellular signals for cellular function","volume":"302","author":"Watt","year":"2012","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1002\/hep.24001","article-title":"Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis","volume":"52","author":"Tilg","year":"2010","journal-title":"Hepatology"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jhep.2021.02.037","article-title":"Muscle Fat Content Is Strongly Associated with NASH: A Longitudinal Study in Patients with Morbid Obesity","volume":"75","author":"Nachit","year":"2021","journal-title":"J. Hepatol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s00223-021-00939-9","article-title":"Fatty Liver Index and Skeletal Muscle Density","volume":"110","author":"Pasco","year":"2022","journal-title":"Calcif. Tissue Int."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"100780","DOI":"10.1016\/j.jhepr.2023.100780","article-title":"Role of ammonia in NAFLD: An unusual suspect","volume":"5","author":"Thomsen","year":"2023","journal-title":"JHEP Rep."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/j.jhep.2016.07.040","article-title":"Sarcopenia from mechanism to diagnosis and treatment in liver disease","volume":"65","author":"Dasarathy","year":"2016","journal-title":"J. Hepatol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1146\/annurev.cellbio.20.012103.135836","article-title":"Regulation of muscle mass by myostatin","volume":"20","author":"Lee","year":"2004","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"101138","DOI":"10.1016\/j.molmet.2020.101138","article-title":"Hepatokines and metabolism: Deciphering communication from the liver","volume":"44","author":"Potthoff","year":"2021","journal-title":"Mol. Metab."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.cmet.2023.01.006","article-title":"The role of hepatokines in NAFLD","volume":"35","author":"Stefan","year":"2023","journal-title":"Cell Metab."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"E250","DOI":"10.1152\/ajpendo.00089.2018","article-title":"Phosphorylation status of fetuin-A is critical for inhibition of insulin action and is correlated with obesity and insulin resistance","volume":"317","author":"Ren","year":"2019","journal-title":"Am. J. Physiol. Endocrinol Metab."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.2337\/db13-0728","article-title":"LECT2 functions as a hepatokine that links obesity to skeletal muscle insulin resistance","volume":"63","author":"Lan","year":"2014","journal-title":"Diabetes"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1111\/liv.13876","article-title":"Sarcopenic obesity in cirrhosis-The confluence of 2 prognostic titans","volume":"38","author":"Eslamparast","year":"2018","journal-title":"Liver Int."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1111\/jgh.16590","article-title":"Positive impact of obesity on the prognosis of liver cirrhosis","volume":"39","author":"Endo","year":"2024","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Emhmed Ali, S., and Nguyen, M.H. (2021). Sarcopenic Obesity in Non-Alcoholic Fatty Liver Disease-The Union of Two Culprits. Life, 11.","DOI":"10.3390\/life11020119"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1002\/hep.26716","article-title":"Relationship between Sarcopenia and Nonalcoholic Fatty Liver Disease: The Korean Sarcopenic Obesity Study","volume":"59","author":"Hong","year":"2014","journal-title":"Hepatology"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/j.1365-2265.2010.03858.x","article-title":"A Prospective Study of the Associations between 25-Hydroxy-Vitamin D, Sarcopenia Progression and Physical Activity in Older Adults","volume":"73","author":"Scott","year":"2010","journal-title":"Clin. Endocrinol."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Barchetta, I., Angelico, F., Ben, M.D., Baroni, M.G., Pozzilli, P., Morini, S., and Cavallo, M.G. (2011). Strong Association between Non Alcoholic Fatty Liver Disease (NAFLD) and Low 25(OH) Vitamin D Levels in an Adult Population with Normal Serum Liver Enzymes. BMC Med., 9.","DOI":"10.1186\/1741-7015-9-85"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1136\/oemed-2020-107094","article-title":"Physical Workload and Increased Frequency of Musculoskeletal Pain: A Cohort Study of Employed Men and Women with Baseline Occasional Pain","volume":"78","author":"Badarin","year":"2021","journal-title":"Occup. Environ. Med."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Kim, Y.-C., Ki, S.-W., Kim, H., Kang, S., Kim, H., and Go, G. (2023). Recent Advances in Nutraceuticals for the Treatment of Sarcopenic Obesity. Nutrients, 15.","DOI":"10.3390\/nu15173854"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.4158\/EP171795.RA","article-title":"Sarcopenia: An Endocrine Disorder?","volume":"23","author":"McKee","year":"2017","journal-title":"Endocri. Pract."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1007\/s12603-018-1139-9","article-title":"International Clinical Practice Guidelines for Sarcopenia (ICFSR): Screening, Diagnosis and Management","volume":"22","author":"Dent","year":"2018","journal-title":"J. Nutr. Health Aging"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"bvad114-1705","DOI":"10.1210\/jendso\/bvad114.1705","article-title":"OR25-06 the Effect of Testosterone Replacement Therapy on NAFLD in Elderly Hypogonadal Men","volume":"7","author":"Lee","year":"2023","journal-title":"J. Endocr. Soc."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"382","DOI":"10.5604\/01.3001.0009.8593","article-title":"Testosterone, Sex Hormone-Binding Globulin and Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis","volume":"16","author":"Jaruvongvanich","year":"2017","journal-title":"Ann. Hepatol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.mce.2017.06.013","article-title":"Development of Selective Androgen Receptor Modulators (SARMs)","volume":"465","author":"Narayanan","year":"2018","journal-title":"Mol. Cell Endocrinol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S1470-2045(13)70055-X","article-title":"Effects of enobosarm on muscle wasting and physical function in patients with cancer: A double-blind, randomised controlled phase 2 trial","volume":"14","author":"Dobs","year":"2013","journal-title":"Lancet Oncol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s11912-016-0522-0","article-title":"Study Design and Rationale for the Phase 3 Clinical Development Program of Enobosarm, a Selective Androgen Receptor Modulator, for the Prevention and Treatment of Muscle Wasting in Cancer Patients (POWER Trials)","volume":"18","author":"Crawford","year":"2016","journal-title":"Curr. Oncol. Rep."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1478-3231.2011.02637.x","article-title":"Growth Hormone, Dehydroepiandrosterone and Adiponectin Levels in Non-Alcoholic Steatohepatitis: An Endocrine Signature for Advanced Fibrosis in Obese Patients","volume":"32","author":"Koehler","year":"2011","journal-title":"Liver Int."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Cristin, L., Montini, A., Martinino, A., Scarano Pereira, J.P., Giovinazzo, F., and Agnes, S. (2023). The Role of Growth Hormone and Insulin Growth Factor 1 in the Development of Non-Alcoholic Steato-Hepatitis: A Systematic Review. Cells, 12.","DOI":"10.3390\/cells12040517"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Cabrera, D., Cabello-Verrugio, C., Sol\u00eds, N., San Mart\u00edn, D., Cofre, C., Pizarro, M., Arab, J.P., Abrigo, J., Campos, F., and Irigoyen, B. (2018). Somatotropic Axis Dysfunction in Non-Alcoholic Fatty Liver Disease: Beneficial Hepatic and Systemic Effects of Hormone Supplementation. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19051339"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1093\/gerona\/glt187","article-title":"Growth hormone replacement therapy prevents sarcopenia by a dual mechanism: Improvement of protein balance and of antioxidant defenses","volume":"69","author":"Brioche","year":"2014","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Bian, A., Ma, Y., Zhou, X., Guo, Y., Wang, W., Zhang, Y., and Wang, X. (2020). Association between sarcopenia and levels of growth hormone and insulin-like growth factor-1 in the elderly. BMC Musculoskelet. Disord., 21.","DOI":"10.1186\/s12891-020-03236-y"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/jcsm.12552","article-title":"Recent Developments in the Field of Cachexia, Sarcopenia, and Muscle Wasting: Highlights from the 12th Cachexia Conference","volume":"11","author":"Ebner","year":"2020","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1093\/annonc\/mdx192","article-title":"ROMANA 3: A phase 3 safety extension study of anamorelin in advanced non-small-cell lung cancer (NSCLC) patients with cachexia","volume":"28","author":"Currow","year":"2012","journal-title":"Ann. Oncol."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Kim, Y. (2021). Emerging Treatment Options for Sarcopenia in Chronic Liver Disease. Life, 11.","DOI":"10.3390\/life11030250"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"C1258","DOI":"10.1152\/ajpcell.00105.2009","article-title":"Myostatin reduces Akt\/TORC1\/p70S6K signaling, inhibiting myoblast differentiation and myotube size","volume":"296","author":"Trendelenburg","year":"2009","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1002\/jcsm.12639","article-title":"Safety and Pharmacokinetics of Bimagrumab in Healthy Older and Obese Adults with Body Composition Changes in the Older Cohort","volume":"11","author":"Rooks","year":"2020","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"e2033457","DOI":"10.1001\/jamanetworkopen.2020.33457","article-title":"Effect of Bimagrumab vs Placebo on Body Fat Mass Among Adults With Type 2 Diabetes and Obesity: A Phase 2 Randomized Clinical Trial","volume":"4","author":"Heymsfield","year":"2021","journal-title":"JAMA Netw. Open"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1002\/hep.29107","article-title":"Ammonia Lowering Reverses Sarcopenia of Cirrhosis by Restoring Skeletal Muscle Proteostasis","volume":"65","author":"Kumar","year":"2017","journal-title":"Hepatology"},{"key":"ref_54","first-page":"8182195","article-title":"L-Ornithine L-Aspartate for the Treatment of Sarcopenia in Chronic Liver Disease: The Taming of a Vicious Cycle","volume":"1","author":"Butterworth","year":"2019","journal-title":"Can. J. Gastroenterol. Hepatol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"G241","DOI":"10.1152\/ajpgi.00373.2020","article-title":"Sarcopenia in chronic liver disease: Mechanisms and countermeasures","volume":"320","author":"Allen","year":"2021","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s12944-023-01867-3","article-title":"The Efficacy of L-Carnitine in Patients with Nonalcoholic Steatohepatitis and Concomitant Obesity","volume":"22","author":"Zakharova","year":"2023","journal-title":"Lipids Health Dis."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Savic, D., Hodson, L., Neubauer, S., and Pavlides, M. (2020). The Importance of the Fatty Acid Transporter L-Carnitine in Non-Alcoholic Fatty Liver Disease (NAFLD). Nutrients, 12.","DOI":"10.3390\/nu12082178"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"e270723219177","DOI":"10.2174\/1573399820666230727101141","article-title":"Metformin in Type 2 Diabetes: Evidence for Its Beneficial Effects on Frailty and Sarcopenia","volume":"20","author":"Pyrgioti","year":"2024","journal-title":"Curr. Diabetes Rev."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/s41574-018-0062-9","article-title":"Sarcopenic Obesity in Older Adults: Aetiology, Epidemiology and Treatment Strategies","volume":"14","author":"Batsis","year":"2018","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"685","DOI":"10.4140\/TCP.n.2016.685","article-title":"Liraglutide: A Glucagon-Like Peptide-1 Agonist for Chronic Weight Management","volume":"31","author":"Manigault","year":"2016","journal-title":"Consult. Pharm."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"155639","DOI":"10.1016\/j.metabol.2023.155639","article-title":"Sarcopenic Obesity: Emerging Mechanisms and Therapeutic Potential","volume":"146","author":"Axelrod","year":"2023","journal-title":"Metabolism"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"154724","DOI":"10.1016\/j.metabol.2021.154724","article-title":"Mitochondrial Uncoupler SHC517 Reverses Obesity in Mice without Affecting Food Intake","volume":"117","author":"Chen","year":"2021","journal-title":"Metabolism"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1038\/s41467-020-16298-2","article-title":"Mitochondrial Uncoupler BAM15 Reverses Diet-Induced Obesity and Insulin Resistance in Mice","volume":"11","author":"Alexopoulos","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"e12088","DOI":"10.15252\/emmm.202012088","article-title":"BAM15-Mediated Mitochondrial Uncoupling Protects against Obesity and Improves Glycemic Control","volume":"12","author":"Axelrod","year":"2020","journal-title":"EMBO Mol. Med."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"C502","DOI":"10.1152\/ajpcell.00455.2018","article-title":"Sphingosine-1-Phosphate Analog FTY720 Reverses Obesity but Not Age-Induced Anabolic Resistance to Muscle Contraction","volume":"317","author":"Rivas","year":"2019","journal-title":"AJP Cell Physiol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.18632\/aging.101910","article-title":"Resveratrol Prevents Sarcopenic Obesity by Reversing Mitochondrial Dysfunction and Oxidative Stress via the PKA\/LKB1\/AMPK Pathway","volume":"11","author":"Huang","year":"2019","journal-title":"Aging"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/gerona\/glac135","article-title":"Supplementing Glycine and N-Acetylcysteine (GlyNAC) in Older Adults Improves Glutathione Deficiency, Oxidative Stress, Mitochondrial Dysfunction, Inflammation, Physical Function, and Aging Hallmarks: A Randomized Clinical Trial","volume":"78","author":"Kumar","year":"2023","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/s00125-011-2446-4","article-title":"Impact of Current Treatments on Liver Disease, Glucose Metabolism and Cardiovascular Risk in Non-Alcoholic Fatty Liver Disease (NAFLD): A Systematic Review and Meta-Analysis of Randomised Trials","volume":"55","author":"Musso","year":"2012","journal-title":"Diabetologia"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s42000-018-0049-x","article-title":"Sarcopenic Obesity","volume":"17","author":"Polyzos","year":"2018","journal-title":"Hormones"},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Kim, J., Baek, Y., Jeong, K., and Lee, S. (2022). Association of Dietary Factors with Grip Strength, Body Fat, and Prevalence of Sarcopenic Obesity in Rural Korean Elderly with Cardiometabolic Multimorbidity. Front. Nutr., 9.","DOI":"10.3389\/fnut.2022.910481"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"111386","DOI":"10.1016\/j.nut.2021.111386","article-title":"A Lacto-Ovo-Vegetarian Dietary Pattern Is Protective against Sarcopenic Obesity: A Cross-Sectional Study of Elderly Chinese People","volume":"91","author":"Chen","year":"2021","journal-title":"Nutrition"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1016\/j.dsx.2019.06.023","article-title":"The Association between Sarcopenic Obesity (SO) and Major Dietary Patterns in Overweight and Obese Adult Women","volume":"13","author":"Rasaei","year":"2019","journal-title":"Diabetes Metab. Syndr."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/s41575-021-00472-y","article-title":"Dietary Carbohydrates and Fats in Nonalcoholic Fatty Liver Disease","volume":"18","author":"Luukkonen","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jhep.2024.04.031","article-title":"EASL\u2013EASD\u2013EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)","volume":"81","author":"Tacke","year":"2024","journal-title":"J. Hepatol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1007\/s00535-021-01833-9","article-title":"Clinical Practice Advice on Lifestyle Modification in the Management of Nonalcoholic Fatty Liver Disease in Japan: An Expert Review","volume":"56","author":"Kamada","year":"2021","journal-title":"J. Gastroenterol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s00394-012-0355-z","article-title":"A Moderate Weight Reduction through Dietary Intervention Decreases Hepatic Fat Content in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD): A Pilot Study","volume":"52","author":"Volynets","year":"2012","journal-title":"Eur. J. Nutr."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1055\/s-0041-1723751","article-title":"Effects of Mediterranean Diet in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review, Meta-Analysis, and Meta-Regression Analysis of Randomized Controlled Trials","volume":"41","author":"Kawaguchi","year":"2021","journal-title":"Semin. Liver Dis."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1136\/gutjnl-2020-323106","article-title":"Effect of Green-Mediterranean Diet on Intrahepatic Fat: The DIRECT plus Randomised Controlled Trial","volume":"70","author":"Meir","year":"2021","journal-title":"Gut"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1053\/j.gastro.2009.01.048","article-title":"Dietary Fat and Carbohydrates Differentially Alter Insulin Sensitivity during Caloric Restriction","volume":"136","author":"Kirk","year":"2009","journal-title":"Gastroenterology"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.3945\/ajcn.110.007674","article-title":"Short-Term Weight Loss and Hepatic Triglyceride Reduction: Evidence of a Metabolic Advantage with Dietary Carbohydrate Restriction","volume":"93","author":"Browning","year":"2011","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1002\/jcsm.12922","article-title":"Systematic Review and Meta-Analysis of Protein Intake to Support Muscle Mass and Function in Healthy Adults","volume":"13","author":"Nunes","year":"2022","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.advnut.2023.04.001","article-title":"Nutrition and Exercise Interventions to Improve Body Composition for Persons with Overweight or Obesity near Retirement Age: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials","volume":"14","author":"Eglseer","year":"2023","journal-title":"Adv. Nutr."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"29","DOI":"10.7762\/cnr.2023.12.1.29","article-title":"Association between Protein Intake from Different Animal and Plant Origins and the Risk of Non-Alcoholic Fatty Liver Disease: A Case-Control Study","volume":"12","author":"Khazaei","year":"2023","journal-title":"Clin. Nutr. Res."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"5252","DOI":"10.1016\/j.clnu.2021.08.012","article-title":"Dairy Protein Intake Is Inversely Related to Development of Non-Alcoholic Fatty Liver Disease","volume":"40","author":"Lee","year":"2021","journal-title":"Clin. Nutr."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.jhep.2018.01.015","article-title":"High Red and Processed Meat Consumption Is Associated with Non-Alcoholic Fatty Liver Disease and Insulin Resistance","volume":"68","author":"Webb","year":"2018","journal-title":"J. Hepatol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1159\/000521241","article-title":"Definition and Diagnostic Criteria for Sarcopenic Obesity: ESPEN and EASO Consensus Statement","volume":"15","author":"Donini","year":"2022","journal-title":"Obes. Facts"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1002\/hep.25762","article-title":"The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association","volume":"55","author":"Chalasani","year":"2012","journal-title":"Hepatology"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.jhep.2013.05.044","article-title":"From NAFLD in clinical practice to answers from guidelines","volume":"59","author":"Nascimbeni","year":"2013","journal-title":"J. Hepatol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jhep.2016.08.023","article-title":"Aerobic vs. resistance exercise in non-alcoholic fatty liver disease: A systematic review","volume":"66","author":"Hashida","year":"2017","journal-title":"J. Hepatol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"3937842","DOI":"10.1155\/2017\/3937842","article-title":"Concurrent Aerobic and Resistance Training Has Anti-Inflammatory Effects and Increases Both Plasma and Leukocyte Levels of IGF-1 in Late Middle-Aged Type 2 Diabetic Patients","volume":"2017","author":"Annibalini","year":"2017","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1152\/physrev.90100.2007","article-title":"Muscle as an endocrine organ: Focus on muscle-derived interleukin-6","volume":"88","author":"Pedersen","year":"2008","journal-title":"Physiol. Rev."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.2147\/CIA.S206522","article-title":"Strength training with blood flow restriction\u2014A novel therapeutic approach for older adults with sarcopenia? A case report","volume":"14","author":"Lopes","year":"2019","journal-title":"Clin. Interv. Aging"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"100171","DOI":"10.1016\/j.jhepr.2020.100171","article-title":"Contribution of Sarcopenia and Physical Inactivity to Mortality in People with Non-Alcoholic Fatty Liver Disease","volume":"2","author":"Golabi","year":"2020","journal-title":"JHEP Rep."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1002\/hep.29003","article-title":"A Practical Approach to Nutritional Screening and Assessment in Cirrhosis","volume":"65","author":"Tandon","year":"2017","journal-title":"Hepatology"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/lt.24958","article-title":"Exercise and Physical Activity for Patients with End-Stage Liver Disease: Improving Functional Status and Sarcopenia While on the Transplant Waiting List","volume":"24","author":"Ferrando","year":"2018","journal-title":"Liver Transplant."},{"key":"ref_96","first-page":"9630","article-title":"Impact of Exercise Training on the Sarcopenia Criteria in Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis","volume":"31","author":"Gonzalez","year":"2021","journal-title":"Eur. J. Transl. Myol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"600","DOI":"10.5009\/gnl220345","article-title":"Independent and Synergistic Associations of Aerobic Physical Activity and Resistance Exercise with Nonalcoholic Fatty Liver Disease","volume":"17","author":"Yang","year":"2023","journal-title":"Gut Liver"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"485","DOI":"10.5009\/gnl230236","article-title":"Aerobic and Resistance Exercise: Synergistic Influence for Nonalcoholic Fatty Liver Disease","volume":"17","author":"Chun","year":"2023","journal-title":"Gut Liver"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1056\/NEJMoa066254","article-title":"Effects of Bariatric Surgery on Mortality in Swedish Obese Subjects","volume":"357","author":"Narbro","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S1470-2045(09)70159-7","article-title":"Effects of Bariatric Surgery on Cancer Incidence in Obese Patients in Sweden (Swedish Obese Subjects Study): A Prospective, Controlled Intervention Trial","volume":"10","author":"Gummesson","year":"2009","journal-title":"Lancet Oncol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1001\/jama.2011.1914","article-title":"Bariatric Surgery and Long-Term Cardiovascular Events","volume":"307","author":"Peltonen","year":"2012","journal-title":"JAMA"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1056\/NEJMoa1600869","article-title":"Bariatric Surgery versus Intensive Medical Therapy for Diabetes\u20145-Year Outcomes","volume":"376","author":"Schauer","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1056\/NEJMoa066603","article-title":"Long-Term Mortality After Gastric Bypass Surgery","volume":"357","author":"Adams","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1001\/jama.2021.19569","article-title":"Association of Bariatric Surgery with Major Adverse Liver and Cardiovascular Outcomes in Patients with Biopsy-Proven Nonalcoholic Steatohepatitis","volume":"326","author":"Aminian","year":"2021","journal-title":"JAMA"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1053\/j.gastro.2020.06.006","article-title":"Bariatric Surgery Provides Long-Term Resolution of Nonalcoholic Steatohepatitis and Regression of Fibrosis","volume":"159","author":"Lassailly","year":"2020","journal-title":"Gastroenterology"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/cld.1229","article-title":"Improvement in Nonalcoholic Fatty Liver Disease through Bariatric Surgery","volume":"20","author":"Truong","year":"2022","journal-title":"Clin. Liver Dis."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"74","DOI":"10.7326\/M21-1962","article-title":"Gastric Bypass Versus Sleeve Gastrectomy in Type 2 Diabetes: Effects on Hepatic Steatosis and Fibrosis: A Randomized Controlled Trial","volume":"175","author":"Seeberg","year":"2022","journal-title":"Ann. Intern. Med."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1016\/S0140-6736(23)00634-7","article-title":"Bariatric\u2013Metabolic Surgery versus Lifestyle Intervention plus Best Medical Care in Non-Alcoholic Steatohepatitis (BRAVES): A Multicentre, Open-Label, Randomised Trial","volume":"401","author":"Verrastro","year":"2023","journal-title":"Lancet"},{"key":"ref_109","first-page":"362","article-title":"Prevalence of Sarcopenia in Women at Stable Weight Phase after Roux-En-Y Gastric Bypass","volume":"66","author":"Buzza","year":"2022","journal-title":"Arch. Endocrinol. Metab."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.clnesp.2022.03.009","article-title":"Prevalence of Low Skeletal Muscle Mass Following Bariatric Surgery","volume":"49","author":"Molero","year":"2022","journal-title":"Clin. Nutr. ESPEN"},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Voican, C.S., Lebrun, A., Maitre, S., Lainas, P., Lamouri, K., Njike-Nakseu, M., Gaillard, M., Tranchart, H., Balian, A., and Dagher, I. (2018). Predictive Score of Sarcopenia Occurrence One Year after Bariatric Surgery in Severely Obese Patients. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0197248"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1007\/s11695-018-3169-0","article-title":"Preoperative Detection of Sarcopenic Obesity Helps to Predict the Occurrence of Gastric Leak After Sleeve Gastrectomy","volume":"28","author":"Gaillard","year":"2018","journal-title":"Obes. Surg."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"511","DOI":"10.3945\/an.116.014506","article-title":"Preserving Healthy Muscle during Weight Loss","volume":"8","author":"Cava","year":"2017","journal-title":"Adv. Nutr."},{"key":"ref_114","first-page":"367.e5","article-title":"Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis","volume":"149","author":"Friedman","year":"2015","journal-title":"Gastroenterology"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1007\/s12325-018-0856-0","article-title":"Understanding Patient Preferences and Unmet Needs in Non-alcoholic Steatohepatitis (NASH): Insights from a Qualitative Online Bulletin Board Study","volume":"36","author":"Cook","year":"2019","journal-title":"Adv. Ther."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"119","DOI":"10.15517\/ap.v30i121.23458","article-title":"Health action process approach (HAPA) as a theoretical framework to understand behavior change","volume":"30","author":"Schwarzer","year":"2016","journal-title":"Actual. En Psicol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/j.1365-2036.2007.03426.x","article-title":"Health-related quality of life in patients with non-alcoholic fatty liver disease","volume":"26","author":"Dan","year":"2007","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"Montemayor, S., Mascar\u00f3, C.M., Ugarriza, L., Casares, M., Llompart, I., Abete, I., Zulet, M.\u00c1., Mart\u00ednez, J.A., Tur, J.A., and Bouzas, C. (2022). Adherence to Mediterranean Diet and NAFLD in Patients with Metabolic Syndrome: The FLIPAN Study. Nutrients, 14.","DOI":"10.3390\/nu14153186"},{"key":"ref_119","doi-asserted-by":"crossref","unstructured":"Cacciatore, S., Calvani, R., Marzetti, E., Picca, A., Coelho-J\u00fanior, H.J., Martone, A.M., Massaro, C., Tosato, M., and Landi, F. (2023). Low Adherence to Mediterranean Diet Is Associated with Probable Sarcopenia in Community-Dwelling Older Adults: Results from the Longevity Check-Up (Lookup) 7+ Project. Nutrients, 15.","DOI":"10.3390\/nu15041026"}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/17\/1\/178\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T10:22:05Z","timestamp":1759918925000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/17\/1\/178"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,2]]},"references-count":119,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1]]}},"alternative-id":["nu17010178"],"URL":"https:\/\/doi.org\/10.3390\/nu17010178","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,2]]}}}